http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2011107440-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D489-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D489-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D489-12
filingDate 2009-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2012-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2011107440-A
titleOfInvention BUPRENOFIN ANALOGUES
abstract 1. The compound of Formula III:! ! where R1 is selected from - (C1-C10) alkyl, - (C2-C12) alkenyl, - (C2-C12) alkynyl, - (C3-C12) cycloalkyl, - (C4-C12) cycloalkenyl, ((C3-C12 ) cycloalkyl) - (C1-C6) alkyl-, ((C4-C12) cycloalkenyl) - (C1-C6) alkyl-, - (5-12 membered) aryl, - ((5-12 membered) aryl) - (C1-C6) alkyl-, - (5-12 membered) heteroaryl, - (3-12 membered) heterocycle, phenyl and benzyl; any of which is optionally substituted with 1, 2, or 3 substituents independently selected from the group consisting of - (C1-C6) alkyl, OH, halo, —C (halo) 3, —CH (halo) 2, —CH2 (halo ), NH2, -NH (C1-C6) alkyl, CN and SH, - (5-12 membered) carbocyclic ring, - (5-12 membered) heterocycle, phenyl and benzyl; ! R2 and R8 are each independently hydrogen, - (C1-C10) alkyl, - (C2-C12) alkenyl, - (C2-C12) alkynyl, - (C3-C12) cycloalkyl, - ((C3-C12) cycloalkyl) - (C1-C6) alkyl, - (C4-C12) cycloalkenyl, (C6-C14) bicycloalkyl, - (C8-C20) tricycloalkyl, - (C7-C14) bicycloalkenyl, - (C8-C20) tricycloalkenyl, - (5 12-membered) aryl, - ((5-12 membered) aryl) - (C1-C6) alkyl -, - (7-12 membered) bicyclic ring system, - (7-12 membered) bicyclic aryl, - (5-12 membered) heteroaryl, - (3-12 membered) heterocycle, - (7-12 membered) bicycloheterocycle, phenyl and benzyl; any of which is optionally substituted with one or two substituents independently selected from the group consisting of OH, (= O), halo, -C (halo) 3, -CH (halo) 2, -CH2 (halo), - (C1 -C6) alkyl, halo (C1-C6) alkyl-, - (C2-C6) alkenyl, - (C2-C6) alkynyl, hydroxy (C1-C6) alkyl-, phenyl, benzyl, NH2, -NH (C1- C6) alkyl, CN, SH and OR4, CONR5R6 and COOR7; ! R3a and R3b are each independently selected from hydrogen, - (C1-C6) alkyl, - (C2-C6) alkenyl, - (C2-C6) alkynyl, OH, hydroxy (C1-C6) alkyl-, (= O), -C (halo) 3, -CH (halo) 2, and -CH2 (halo); ! R4 is selected from - (C1-C6) alkyl, - (C2-C6) alkenyl, - (C2-C6) alkynyl, -C (halo) 3, hydroxy (C1-C6) alkyl-, - (C3-C12) cycloalkyl, - (C6-C14) bicyc
priorityDate 2008-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468024471
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP47748
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394280
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18389
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416115865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393661
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP79292
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393737
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393375
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP41146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393376
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID402851
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29256
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457815269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456459936
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1268256
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456464034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393707
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394273
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100135588
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35377
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455784172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457493196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393346
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456087053
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4987

Total number of triples: 55.